Penwest Pharmaceuticals (PPCO)
$2.34
0.08 (+3.54%)
| CAPS Rating |
|
|---|---|
| Open | $2.24 |
| Previous Close | $2.26 |
| Daily Range | $2.24 - $2.40 |
| 52-Week Range | $0.44 - $3.26 |
| Market Cap | $74.33M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 2,043 |
| Average Daily Volume | 45,000 |
This ticker is not currently Ratable.
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
PPCO Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
PPCO News and Commentary
- The Endo a Patent? – The Motley Fool
- Monday's Worst Stocks in the World – The Motley Fool
- The Two Sides of Endo – The Motley Fool
- Thursday's Worst Stocks in the World – The Motley Fool
- The Contrarian Shopping List – The Motley Fool
Related News and Articles
- A Mostly Meaningless FDA Approval – The Motley Fool
- Biotech Bargains for Your Portfolio – The Motley Fool
- 7 of the Most Efficient Companies on the Planet – The Motley Fool
- 5-Star Stocks Poised to Pop: Diageo – The Motley Fool
- 3 China Profit Plays – The Motley Fool
- A Big Upgrade for Amylin Pharmaceuticals – The Motley Fool
- Build Your Fortune With These Winners – The Motley Fool
- Still Enjoying Those Acquisitions, Pfizer? – The Motley Fool
- Novartis Didn't Know JAK, Until Now – The Motley Fool
- 12 Companies With Ironclad Balance Sheets – The Motley Fool
- 7 Dividend Divas – The Motley Fool
- A Schizophrenic Move by Merck? – The Motley Fool
- Do Good Without Being a Corporate Hotshot – The Motley Fool


RSS Headlines
Fool UK